When Columbia University posted a press release in February 2018 about a promising new proof-of-concept study of the Tick-Borne Disease Serochip (TBD Serochip), the press office soon had to amend the announcement with an update for the public: no, the test is not available yet; no, you can’t enroll in a clinical trial or send specimens; and no, they […]
The current developments, product launches and company plans in IVD testing on smartphone platforms has been detailed by Kalorama Information in a recent report by Kalorama’s Rob Camp: https://www.kaloramainformation.com/Smartphone-Based-IVD-Products-Trends-Potential-12019398/ We summarize some of the findings of our study here. This represents a fraction of the findings of the report: The techniques that can most successfully harness […]
We at Kalorama Information have just released the Eleventh Edition of our flagship publication,The Worldwide Market for In Vitro Diagnostics. This report has been updated for two decades, keeping readers informed about developments in all areas of the IVD industry, around the world, in one volume. At 1,800 pages, the report provides market size estimates and projections […]
In many ways, the IVD market of today does not resemble the market five years ago. 2018 appears to be the year where a number of trends that had been discussed began to gel. With that in mind, Kalorama Information will be on hand for UBM’s BIOMedDevice Convention in San Jose, CA next month. In […]
China’s IVD market reached $3,200 million in 2017, in line with growth estimates published by Kalorama and elsewhere, and the fast pace of market growth is expected to continue. Supporting growth will be a modernizing healthcare infrastructure and steady migration from manual to automated processes. This was the conclusion of Kalorama Information’s recent report, IVD in […]
Multiplex Immunoassays Could Develop as a Cheaper Panel Testing Option for Tropical Diseases Kalorama Information reports cover the related global markets for point of care (POC) diagnostics and molecular POC diagnostics. Make sure to visit our Point of Care Testing page, Kalorama’s all-in-one resource covering the POC testing market. The sensitivity and specificity of nucleic acid analytes provide molecular […]
Kalorama Information covers in vitro diagnostics (IVD) markets for autism spectrum disorders (ASDs) and other psychiatric disorders in The World Molecular Diagnostics Market, 7thEd. and Novel Autism Diagnostics. In two recent studies, in vitro diagnostic (IVD) assays have been investigated that incorporate biomarkers for environmental factors and dysfunctional cellular pathways associated with autism spectrum disorders (ASDs). The accuracy […]
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
